- Know Labs’ Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study
- Know Labs Secures U.S. $12 Million Funding for Company’s Further Execution on Its Clinical Research and Development Initiatives
- Know Labs Announces the KnowU™, its Wearable Non-Invasive Continuous Glucose Monitor
- Know Labs, Inc. Reports First Quarter FY2024 Results
- Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2024 Results on February 14, 2024
- Know Labs to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
More ▼
Key statistics
On Wednesday, Know Labs Inc (KNW:ASQ) closed at 0.638, 177.39% above the 52 week low of 0.23 set on Sep 29, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.612 |
---|---|
High | 0.66 |
Low | 0.600 |
Bid | 0.600 |
Offer | 0.6999 |
Previous close | 0.638 |
Average volume | 61.50k |
---|---|
Shares outstanding | 81.35m |
Free float | 56.53m |
P/E (TTM) | -- |
Market cap | 51.90m USD |
EPS (TTM) | -0.3801 USD |
Data delayed at least 15 minutes, as of Mar 27 2024 20:10 BST.
More ▼